Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786656 · ClinicalTrials.gov registry record
Community Cancer Centers Pilot Patient Survey
A clinical trial of Cancer and Malignant Neoplasms, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 3,955
- Enrollment target
- 1
- Study location
NCT00786656: Completed study of Cancer and Malignant Neoplasms, sponsored by National Cancer Institute (NCI).
NCT00786656 is a study of Cancer and Malignant Neoplasms that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 3,955 participants, above the 3,485-participant average among 615 other Cancer trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00786656, a study of Cancer and Malignant Neoplasms, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 3,955 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: * Studies suggest that cancer patients diagnosed and treated in a facility with multi-specialty care and clinical research may live longer and have a better quality of life than patients treated elsewhere. * The NCI Community Cancer Centers Pilot Program (NCCCP) is a 3-year program to test the concept of a national network of community cancer centers to expand cancer research and deliver the most advanced cancer care to Americans in their own communities. * The pilot program includes a survey of cancer patients receiving care at the pilot sites. Objectives: * To gain an understanding of the experiences of adult patients who receive services at the NCCCP pilot sites and assess if and how their experience changes over the study period. Data about the following are collected: * Patients information needs and awareness of the NCCCP program * Clinical trials experience * Access to health care * Perspectives on patient-provider communication * Experiences with patient navigation, self-management, medical decision-making and survivorship * Satisfaction with care and quality of life Eligibility: * Patients 21 years or older at the time of diagnosis * Treatment at the cancer center for at least 3 months since July 1, 2007 Design: * Participants complete a 25-minute questionnaire covering the care they received at their cancer center, their experience with making medical appointments and how long they waited to see the doctor. The survey includes information on the following: * Services at the cancer center * Getting needed care * Assistance for patients and their families * Communication with the cancer care team * Clinical trials * Care after finishing treatment * Evaluation of care * Health and medical history * Background information (demographics)
Conditions Studied
Study Locations (1)
North Carolina
- Research Triangle Institute International - Research Triangle Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,955 participants |
| Start Date | 2008-11-03 |
| Est. Completion | 2015-05-11 |
What the finished NCT00786656 record still lists
NCT00786656 is an observational study that tracks outcomes without assigning an intervention. Its 3,955 participants enrollment target places it among the larger protocols in the corpus, above the 3,485-participant average among 615 other Cancer trials with a reported enrollment target (13% higher).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00786656 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00786656 about?
NCT00786656 is a clinical study titled "Community Cancer Centers Pilot Patient Survey". Background: * Studies suggest that cancer patients diagnosed and treated in a facility with multi-specialty care and clinical research may live longer and have a better quality of life than patients treated elsewhere. * The NCI Community Cancer Centers Pilot Program (NCCCP) is a 3-year program to t...
What is the current status of trial NCT00786656?
This trial is currently completed. The enrollment target is 3,955 participants. The study started on 2008-11-03. Estimated completion is 2015-05-11.
What conditions does trial NCT00786656 study?
This clinical trial studies the following conditions: Cancer, Malignant Neoplasms.
Who is sponsoring clinical trial NCT00786656?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00786656 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00786656's enrollment target sits among peer trials
3,955 47th of 615 higher than 569 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05879926 · 3,960 participants · Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI